Boston Scientific Corporation BSX
NYSE
Recommendation
Dividend Power Score
Day's Range
$41.92$43.23
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -5.59% | 4.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.59% | 4.59% | |||
| Cost of Revenue | 7.22% | 0.25% | |||
| Gross Profit | -10.95% | 6.53% | |||
| SG&A Expenses | -6.66% | 1.24% | |||
| Depreciation & Amortization | 0.43% | 0.43% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.88% | 1.57% | |||
| Operating Income | -21.43% | 16.23% | |||
| Income Before Tax | -30.85% | -8.86% | |||
| Income Tax Expenses | -1.29% | 188.07% | |||
| Earnings from Continuing Operations | -35.91% | -32.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 0.00% | |||
| Net Income | -35.83% | -32.36% | |||
| EBIT | -21.43% | 16.23% | |||
| EBITDA | -16.30% | 12.51% | |||
| EPS Basic | -34.88% | -31.69% | |||
| Normalized Basic EPS | -24.44% | 15.22% | |||
| EPS Diluted | -34.43% | -32.22% | |||
| Normalized Diluted EPS | -24.38% | 15.63% | |||
| Average Basic Shares Outstanding | -1.46% | -0.99% | |||
| Average Diluted Shares Outstanding | -1.55% | -1.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||